Exhibit (a)(5)(4)
The accompanying unaudited pro forma consolidated statements of operations and financial ratios for the year ended December 31, 2011 and the nine months ended September 30, 2011 give effect to our repurchase of the Notes as if the Notes were repurchased at the end of all periods presented. The accompanying unaudited pro forma consolidated balance sheet as of December 31, 2011 gives effect to our repurchase of the Notes as if the Notes were repurchased as of December 31, 2011.
The historical financial information on which the pro forma information is based is included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, which was filed on March 5, 2012, and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, which was filed on November 14, 2011. The pro forma information and the notes thereto should be read in conjunction with these historical consolidated financial statements.
The unaudited pro forma information are presented for illustrative purposes only and are subject to a number of assumptions which may not be indicative of the results of operations that would have occurred had the Notes been repurchased at the dates indicated or what the results will be for any future periods.
VERENIUM CORPORATION
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET
AS OF DECEMBER 31, 2011
(in thousands, except per share data)
| | | | | | | | | | | | |
| | Historical | | | Pro Forma Adjustments | | | Pro Forma | |
ASSETS | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | |
Cash and cash equivalents | | $ | 28,759 | | | | (35,330 | )(c) | | $ | (6,571 | ) |
Restricted cash | | | 5,000 | | | | | | | | 5,000 | |
Accounts receivable, net of allowance for doubtful accounts of $0.1 million | | | 11,371 | | | | | | | | 11,371 | |
Inventories, net | | | 6,323 | | | | | | | | 6,323 | |
Prepaid expenses and other current assets | | | 2,396 | | | | | | | | 2,396 | |
| | | | | | | | | | | | |
Total current assets | | | 53,849 | | | | | | | | 18,519 | |
Property and equipment, net | | | 7,806 | | | | | | | | 7,806 | |
Restricted cash | | | 3,200 | | | | | | | | 3,200 | |
Other long term assets | | | 482 | | | | (73 | )(d) | | | 409 | |
| | | | | | | | | | | | |
Total assets | | $ | 65,337 | | | | | | | $ | 29,934 | |
| | | | | | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | |
Accounts payable | | $ | 8,543 | | | | | | | $ | 8,543 | |
Accrued expenses | | | 6,123 | | | | (479 | )(e) | | | 5,644 | |
Deferred revenue | | | 4,137 | | | | | | | | 4,137 | |
Accrued restructuring | | | 396 | | | | | | | | 396 | |
Convertible debt, at carrying value (face value of $34.9 million) | | | 34,851 | | | | (34,851 | )(f) | | | — | |
Current liabilities of discontinued operations | | | 436 | | | | | | | | 436 | |
| | | | | | | | | | | | |
Total current liabilities | | | 54,486 | | | | | | | | 19,156 | |
Other long term liabilities | | | 889 | | | | | | | | 889 | |
Long term liabilities of discontinued operations | | | 17 | | | | | | | | 17 | |
| | | | | | | | | | | | |
Total liabilities | | | 55,392 | | | | | | | | 20,062 | |
Stockholders’ equity: | | | | | | | | | | | | |
Preferred stock—$0.001 par value; 5,000 shares authorized, no shares issued and outstanding | | | — | | | | | | | | — | |
Common Stock—$0.001 par value; 245,000 shares authorized; 12,611 shares issued and outstanding | | | 12 | | | | | | | | 12 | |
Additional paid-in capital | | | 610,781 | | | | | | | | 610,781 | |
Accumulated deficit | | | (600,848 | ) | | | (73 | )(d) | | | (600,921 | ) |
| | | | | | | | | | | | |
Total stockholders’ equity | | | 9,945 | | | | | | | | 9,872 | |
| | | | | | | | | | | | |
Total liabilities and stockholders’ equity | | $ | 65,337 | | | | | | | $ | 29,934 | |
| | | | | | | | | | | | |
(c) | Adjustment to remove cash paid for principal of $34.9 million and accrued and unpaid interest of $0.5 million as if the Notes were repurchased as of December 31, 2011. |
(d) | Adjustment to remove the capatilized debt issuance cost balance as if the Notes were repurchased as of December 31, 2011. |
(e) | Adjustment to remove the accrued and unpaid interest balance as if the Notes were repurchased as of December 31, 2011. |
(f) | Adjustment to remove the Notes principal balance as if the Notes were repurchased as of December 31, 2011. |
VERENIUM CORPORATION
UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2011
(in thousands, except per share data)
| | | | | | | | | | | | |
| | Historical | | | Pro Forma Adjustments | | | Pro Forma | |
Revenue: | | | | | | | | | | | | |
Product | | $ | 55,995 | | | | | | | $ | 55,995 | |
Collaborative and license | | | 5,272 | | | | | | | | 5,272 | |
| | | | | | | | | | | | |
Total revenue | | | 61,267 | | | | | | | | 61,267 | |
Operating expenses: | | | | | | | | | | | | |
Cost of product revenue | | | 34,481 | | | | | | | | 34,481 | |
Research and development | | | 10,986 | | | | | | | | 10,986 | |
Selling, general and administrative | | | 19,365 | | | | | | | | 19,365 | |
Restructuring charges | | | 2,943 | | | | | | | | 2,943 | |
| | | | | | | | | | | | |
Total operating expenses | | | 67,775 | | | | | | | | 67,775 | |
| | | | | | | | | | | | |
Loss from operations | | | (6,508 | ) | | | | | | | (6,508 | ) |
Other income and expenses: | | | | | | | | | | | | |
Interest and other income, net | | | 56 | | | | | | | | 56 | |
Interest expense | | | (3,062 | ) | | | | | | | (3,062 | ) |
Gain on debt extinguishment upon repurchase of convertible notes | | | 15,349 | | | | (73 | )(d) | | | 15,276 | |
Loss on net change in fair value of derivative assets and liabilities | | | (964 | ) | | | | | | | (964 | ) |
| | | | | | | | | | | | |
Total other income and (expenses), net | | | 11,379 | | | | | | | | 11,306 | |
Net income from continuing operations before income taxes | | | 4,871 | | | | | | | | 4,798 | |
Income tax benefit | | | 368 | | | | | | | | 368 | |
| | | | | | | | | | | | |
Net income from continuing operations | | | 5,239 | | | | | | | | 5,166 | |
| | | | | | | | | | | | |
Net loss from discontinued operations | | | (112 | ) | | | | | | | (112 | ) |
| | | | | | | | | | | | |
Net income attributed to Verenium Corporation | | $ | 5,127 | | | | | | | $ | 5,054 | |
| | | | | | | | | | | | |
Net income (loss) per share, basic and diluted: | | | | | | | | | | | | |
Continuing operations | | $ | 0.42 | | | | | | | $ | 0.40 | |
| | | | | | | | | | | | |
Discontinued operations | | $ | (0.01 | ) | | | | | | $ | (0.01 | ) |
| | | | | | | | | | | | |
Attributed to Verenium Corporation | | $ | 0.41 | | | | | | | $ | 0.40 | |
| | | | | | | | | | | | |
Weighted average shares used in calculating basic and diluted net income (loss) per share | | | 12,608 | | | | | | | | 12,608 | |
| | | | | | | | | | | | |
(d) | Adjustment to show the loss on debt extinguishment related to the write off of the capitalized debt issuance cost balance as if the Notes were repurchased as of December 31, 2011. |
VERENIUM CORPORATION
UNAUDITED PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2011
(in thousands, except per share data)
| | | | | | | | | | | | |
| | Historical | | | Pro Forma Adjustments | | | Pro Forma | |
Revenue: | | | | | | | | | | | | |
Product | | $ | 42,252 | | | | | | | $ | 42,252 | |
Collaborative and license | | | 4,694 | | | | | | | | 4,694 | |
| | | | | | | | | | | | |
Total revenue | | | 46,946 | | | | | | | | 46,946 | |
Operating expenses: | | | | | | | | | | | | |
Cost of product revenue | | | 26,174 | | | | | | | | 26,174 | |
Research and development | | | 7,593 | | | | | | | | 7,593 | |
Selling, general and administrative | | | 14,106 | | | | | | | | 14,106 | |
Restructuring charges | | | 2,940 | | | | | | | | 2,940 | |
| | | | | | | | | | | | |
Total operating expenses | | | 50,813 | | | | | | | | 50,813 | |
| | | | | | | | | | | | |
Loss from operations | | | (3,867 | ) | | | | | | | (3,867 | ) |
Other income and expenses: | | | | | | | | | | | | |
Interest and other income, net | | | 50 | | | | | | | | 50 | |
Interest expense | | | (2,421 | ) | | | | | | | (2,421 | ) |
Gain on debt extinguishment upon repurchase of convertible notes | | | 15,349 | | | | (147 | )(g) | | | 15,202 | |
Loss on net change in fair value of derivative assets and liabilities | | | (1,005 | ) | | | | | | | (1,005 | ) |
| | | | | | | | | | | | |
Total other income and (expenses), net | | | 11,973 | | | | | | | | 11,826 | |
Net income from continuing operations before income taxes | | | 8,106 | | | | | | | | 7,959 | |
Income tax benefit | | | — | | | | | | | | — | |
| | | | | | | | | | | | |
Net income from continuing operations | | | 8,106 | | | | | | | | 7,959 | |
| | | | | | | | | | | | |
Net income from discontinued operations | | | 37 | | | | | | | | 37 | |
| | | | | | | | | | | | |
Net income attributed to Verenium Corporation | | $ | 8,143 | | | | | | | $ | 7,996 | |
| | | | | | | | | | | | |
Net income per share, basic and diluted: | | | | | | | | | | | | |
Continuing operations | | $ | 0.64 | | | | | | | $ | 0.63 | |
| | | | | | | | | | | | |
Discontinued operations | | $ | 0.00 | | | | | | | $ | 0.00 | |
| | | | | | | | | | | | |
Attributed to Verenium Corporation | | $ | 0.65 | | | | | | | $ | 0.63 | |
| | | | | | | | | | | | |
Weighted average shares used in calculating basic and diluted net income (loss) per share | | | 12,607 | | | | | | | | 12,607 | |
| | | | | | | | | | | | |
(g) | Adjustment to show the loss on debt extinguishment related to the write off of the capitalized debt issuance cost balance as if the Notes were repurchased as of September 30, 2011. |
VERENIUM CORPORATION
UNAUDITED PRO FORMA RATIO OF EARNINGS TO FIXED CHARGES
(in thousands, except ratio data)
| | | | | | | | |
| | For the Year Ended December 31, 2011 | | | For the Nine Months Ended September 30, 2011 | |
Earnings: | | | | | | | | |
Pre-tax income from continuing operations | | $ | 4,798 | | | $ | 7,959 | |
Add: Total fixed charges (see details below) | | | 2,945 | | | | 2,392 | |
| | | | | | | | |
Total income before provision for income taxes plus fixed charges | | $ | 7,743 | | | $ | 10,351 | |
| | | | | | | | |
Fixed Charges: | | | | | | | | |
Sum of: | | | | | | | | |
Interest expense(a) | | $ | 2,718 | | | $ | 2,239 | |
Amortized premiums, discounts and capitalized expenes related to indebtedness (b) | | | 227 | | | | 153 | |
| | | | | | | | |
Total fixed charges | | $ | 2,945 | | | $ | 2,392 | |
| | | | | | | | |
Ratio of earnings to fixed charges | | | 2.63 | | | | 4.33 | |
| | | | | | | | |
VERENIUM CORPORATION
UNAUDITED PRO FORMA BOOK VALUE PER SHARE
AS OF DECEMBER 31, 2011
(in thousands, except per share data)
| | | | |
| | Pro Forma | |
Stockholders’ Equity | | $ | 9,872 | |
Outstanding Shares | | | 12,611 | |
| | | | |
Book Value per Share | | $ | 0.78 | |
| | | | |